- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/333 - Radicals substituted by oxygen or sulfur atoms
Patent holdings for IPC class C07D 207/333
Total number of patents in this class: 160
10-year publication summary
17
|
18
|
15
|
16
|
13
|
9
|
9
|
3
|
4
|
5
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Zydus Lifesciences Limited | 114 |
10 |
Takeda Pharmaceutical Company Limited | 2696 |
8 |
Politecnico di Milano | 851 |
6 |
ViiV Healthcare UK (No. 4) Limited | 22 |
5 |
Centre National de La Recherche Scientifique | 10442 |
4 |
Bayer Pharma AG | 1047 |
4 |
Pirelli Tyre S.p.A. | 1913 |
4 |
Janssen Pharmaceutica N.V. | 3384 |
3 |
The Board of Trustees of the University of Illinois | 2695 |
3 |
Cadila Healthcare Limited | 317 |
3 |
Lupin Limited | 432 |
3 |
Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. | 1774 |
3 |
Proteostasis Therapeutics, Inc. | 70 |
3 |
The Trustees of Princeton University | 1204 |
3 |
Vivreon Biosciences, LLC | 3 |
3 |
Syngenta Participations AG | 1900 |
2 |
FUJIFILM Corporation | 29424 |
2 |
Board of Trustees of Michigan State University | 1185 |
2 |
Canopy Growth Corporation | 221 |
2 |
Daiichi Sankyo Company, Limited | 1874 |
2 |
Other owners | 85 |